Qia-Qia Li Selected Research

niraparib

1/2023

Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qia-Qia Li Research Topics

Disease

1	Ascites 01/2023
1	Bites and Stings (Sting) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Hypoxia (Hypoxemia) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Neoplasms (Cancer) 10/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2017
1	Disease Progression 10/2017
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Adenocarcinoma of Lung 10/2017

Drug/Important Bio-Agent (IBA)

1	entinostat (MS 275)IBA 01/2023
1	niraparibIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Long Noncoding RNAIBA 10/2017

Therapy/Procedure

1	Immunotherapy 01/2023
1	Therapeutics 01/2023